Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats

It was reported that the hepatic microsomal cytochrome P450 (CYP) 2CI 1, 2131, and 3A I (not via the CYP1A2, 213 1/2, and 2E1) were involved in the metabolism of metformin in rats. It was also reported that the expressions of CYP2C11 and 3A2 decreased in rats pretreated with Klebsiella pneumoniae lipopolysaccharide (KPLPS). Therefore, the pharmacokinetic parameters of metformin could be changed in rats pretreated with KPLPS. Hence, the pharmacokinctic parameters of metformin were compared after both intravenous and oral administration of the drug at a dose of 100 mg/kg to control rats and rats pretreated with KPLPS. Aftenintraverrous administration of metformin to rats pretreated with KPLPS, the total area under the plasma concentration-time curve from time 0 to infinity (AUC) of the drug was significantly greater (40.5% increase) than the controls due to significantly smaller CL value (27.7% decrease) than the controls. The significantly smaller CL value could be due to significantly smaller both the CLR and CLNR values (34.0% and 18.1% decrease, respectively) than the controls. The significantly smaller CLNR value could be due to decrease in the expressions of CYP2C11 and 3A2 in rats pretreated with KPLPS. After oral administration of metformin, the AUC of the drug was not significantly different between two groups of rats, and this may be at least partly due to decrease in absorption from the gastrointestinal tract compared with the controls. (c) 2007 Elsevier B.V. All rights reserved.